| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.07 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |